Cubist Systematic Strategies’s Fate Therapeutics FATE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $125K | Buy |
+111,512
| New | +$125K | ﹤0.01% | 1277 |
|
2025
Q1 | – | Sell |
-7,776
| Closed | -$12.8K | – | 1724 |
|
2024
Q4 | $12.8K | Buy |
+7,776
| New | +$12.8K | ﹤0.01% | 1386 |
|
2024
Q1 | – | Sell |
-214,345
| Closed | -$802K | – | 2413 |
|
2023
Q4 | $802K | Buy |
214,345
+179,543
| +516% | +$671K | 0.01% | 1201 |
|
2023
Q3 | $73.8K | Sell |
34,802
-420,135
| -92% | -$891K | ﹤0.01% | 1664 |
|
2023
Q2 | $2.17M | Sell |
454,937
-188,182
| -29% | -$896K | 0.01% | 849 |
|
2023
Q1 | $3.67M | Buy |
643,119
+70,570
| +12% | +$402K | 0.02% | 775 |
|
2022
Q4 | $5.78M | Buy |
572,549
+313,923
| +121% | +$3.17M | 0.03% | 588 |
|
2022
Q3 | $5.8M | Sell |
258,626
-108,436
| -30% | -$2.43M | 0.03% | 708 |
|
2022
Q2 | $9.1M | Buy |
367,062
+350,056
| +2,058% | +$8.67M | 0.06% | 402 |
|
2022
Q1 | $659K | Buy |
17,006
+6,410
| +60% | +$248K | 0.01% | 2340 |
|
2021
Q4 | $620K | Sell |
10,596
-70,438
| -87% | -$4.12M | 0.01% | 2289 |
|
2021
Q3 | $4.8M | Buy |
81,034
+62,238
| +331% | +$3.69M | 0.06% | 486 |
|
2021
Q2 | $1.63M | Sell |
18,796
-24,283
| -56% | -$2.11M | 0.02% | 1229 |
|
2021
Q1 | $3.55M | Sell |
43,079
-28,281
| -40% | -$2.33M | 0.05% | 640 |
|
2020
Q4 | $6.49M | Sell |
71,360
-15,112
| -17% | -$1.37M | 0.09% | 320 |
|
2020
Q3 | $3.46M | Buy |
86,472
+86,372
| +86,372% | +$3.45M | 0.05% | 584 |
|
2020
Q2 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 2356 |
|
2020
Q1 | – | Sell |
-44,217
| Closed | -$865K | – | 2241 |
|
2019
Q4 | $865K | Buy |
44,217
+44,212
| +884,240% | +$865K | 0.02% | 1248 |
|
2019
Q3 | $0 | Sell |
5
-4,943
| -100% | – | ﹤0.01% | 2278 |
|
2019
Q2 | $100K | Buy |
4,948
+2,086
| +73% | +$42.2K | ﹤0.01% | 2233 |
|
2019
Q1 | $50K | Sell |
2,862
-18,403
| -87% | -$322K | ﹤0.01% | 2103 |
|
2018
Q4 | $273K | Buy |
+21,265
| New | +$273K | 0.01% | 1348 |
|